Literature DB >> 19001173

Persistence of immunopathological and radiological traits in multiple sclerosis.

Fatima B König1, Brigitte Wildemann, Stefan Nessler, Dun Zhou, Bernhard Hemmer, Imke Metz, Hans-Peter Hartung, Bernd C Kieseier, Wolfgang Brück.   

Abstract

BACKGROUND: Multiple sclerosis (MS) is a heterogeneous autoimmune disease of the central nervous system. The identification of 4 different immunopathological subtypes of MS raises the question of whether these subtypes represent different patient subgroups that can be distinguished according to their leading mechanism of myelin destruction or whether this is a stage-dependent process in the development of lesions in a given patient.
OBJECTIVE: To document intraindividual immunopathological and radiological homogeneity of 2 different lesions in a single patient with relapsing-remitting MS over time.
DESIGN: Case report.
SETTING: A neuropathological referral center for inflammatory demyelinating diseases of the central nervous system. PATIENT: A 49-year-old woman with clinically definite relapsing-remitting MS. MAIN OUTCOME MEASURES: Radiological and immunopathological analysis of MS lesions.
RESULTS: Identical pathological findings in 2 different MS lesions separated by more than 2 years were identified. These lesions displayed similar and distinct radiological features on cranial imaging.
CONCLUSIONS: In this patient we were able to show the same antibody/complement-mediated lesion pathological findings with compatible identical ring enhancement on T1-weighted magnetic resonance images and hypointense rims on T2-weighted images after an interval of 26 months. Our observations support the concept of intraindividual homogeneity of a given immunopathological MS subtype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001173     DOI: 10.1001/archneur.65.11.1527

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  20 in total

1.  Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis.

Authors:  Lidia Stork; David Ellenberger; Tim Beißbarth; Tim Friede; Claudia F Lucchinetti; Wolfgang Brück; Imke Metz
Journal:  JAMA Neurol       Date:  2018-04-01       Impact factor: 18.302

Review 2.  [MOG encephalomyelitis: international recommendations on diagnosis and antibody testing].

Authors:  S Jarius; F Paul; O Aktas; N Asgari; R C Dale; J de Seze; D Franciotta; K Fujihara; A Jacob; H J Kim; I Kleiter; T Kümpfel; M Levy; J Palace; K Ruprecht; A Saiz; C Trebst; B G Weinshenker; B Wildemann
Journal:  Nervenarzt       Date:  2018-12       Impact factor: 1.214

3.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Authors:  Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-09-27       Impact factor: 8.322

4.  Pathologic heterogeneity persists in early active multiple sclerosis lesions.

Authors:  Imke Metz; Stephen D Weigand; Bogdan F G Popescu; Josa M Frischer; Joseph E Parisi; Yong Guo; Hans Lassmann; Wolfgang Brück; Claudia F Lucchinetti
Journal:  Ann Neurol       Date:  2014-05-13       Impact factor: 10.422

Review 5.  Spring cleaning: time to rethink imaging research lines in MS?

Authors:  Martina Absinta; Daniel S Reich; Massimo Filippi
Journal:  J Neurol       Date:  2016-02-17       Impact factor: 4.849

Review 6.  Myelin oligodendrocyte glycoprotein antibodies in neurological disease.

Authors:  Markus Reindl; Patrick Waters
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

7.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.

Authors:  Sven Jarius; Ingo Kleiter; Klemens Ruprecht; Nasrin Asgari; Kalliopi Pitarokoili; Nadja Borisow; Martin W Hümmert; Corinna Trebst; Florence Pache; Alexander Winkelmann; Lena-Alexandra Beume; Marius Ringelstein; Oliver Stich; Orhan Aktas; Mirjam Korporal-Kuhnke; Alexander Schwarz; Carsten Lukas; Jürgen Haas; Kai Fechner; Mathias Buttmann; Judith Bellmann-Strobl; Hanna Zimmermann; Alexander U Brandt; Diego Franciotta; Kathrin Schanda; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-11-01       Impact factor: 8.322

8.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.

Authors:  Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Corinna Trebst; Marius Ringelstein; Orhan Aktas; Alexander Winkelmann; Mathias Buttmann; Alexander Schwarz; Hanna Zimmermann; Alexander U Brandt; Diego Franciotta; Marco Capobianco; Joseph Kuchling; Jürgen Haas; Mirjam Korporal-Kuhnke; Soeren Thue Lillevang; Kai Fechner; Kathrin Schanda; Friedemann Paul; Brigitte Wildemann; Markus Reindl
Journal:  J Neuroinflammation       Date:  2016-09-26       Impact factor: 8.322

9.  MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy.

Authors:  Ryo Ogawa; Ichiro Nakashima; Toshiyuki Takahashi; Kimihiko Kaneko; Tetsuya Akaishi; Yoshiki Takai; Douglas Kazutoshi Sato; Shuhei Nishiyama; Tatsuro Misu; Hiroshi Kuroda; Masashi Aoki; Kazuo Fujihara
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-01-16

10.  Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology.

Authors:  Franziska Di Pauli; Romana Höftberger; Markus Reindl; Ronny Beer; Paul Rhomberg; Kathrin Schanda; Douglas Sato; Kazuo Fujihara; Hans Lassmann; Erich Schmutzhard; Thomas Berger
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.